The ability of ICG-001 to lower blood pressure is comparable to losartan, an AT1 receptor blocker that obliterates Ang II-triggered hypertension by virtue of its ability to block Ang II action in the first place. This evidence concerns the gene AGTR1 and hypertensive disorder.